Characterize drug response at the body scale.
Investigates complex drug biology across integrated tissue systems, linking phenotype to omics for mechanism-of-action and biomarker discovery studies.


Capabilities
O1
Multi-tissue interactions
Study how tissues communicate through shared medium, focusing on efficacy, safety, and liver metabolism.
O2
Mechanism of action
Link phenotypic data with transcriptomic or proteomic readouts to understand drug effects.
O3
Biomarker discovery
Identify tissue-specific and systemic biomarkers that can inform clinical development and patient stratification.
Access an integrated understanding of your drug.
the omics pipeline
partnership models
Predictive biology
starts today




